Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension
- PMID: 31118982
- PMCID: PMC6528109
- DOI: 10.5114/wiitm.2018.80297
Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension
Abstract
Introduction: The role of laparoscopic selective esophagogastric devascularization and splenectomy (LSEGDS) in the treatment of esophagogastric variceal bleeding and hypersplenism in patients with cirrhotic portal hypertension has not been well studied.
Aim: To investigate the safety and efficacy of LSEGDS for esophagogastric variceal bleeding and hypersplenism in patients with cirrhotic portal hypertension.
Material and methods: From May 2011 to December 2014, 74 patients with portal hypertension resulting from liver cirrhosis underwent surgery for gastroesophageal variceal bleeding and hypersplenism. Forty-one of these patients underwent laparoscopic esophagogastric devascularization and splenectomy (LEGDS), and the others underwent LSEGDS. A retrospective comparative analysis of clinical data was conducted between the two groups, including clinical characteristics, laboratory data, operative morbidity and mortality, and outcomes of follow-up.
Results: The operation was completed successfully in all the patients, except that conversion was required in one patient in the LEGDS group. The operating time was similar in both groups (p = 0.579). The intraoperative blood loss was lower in the LSEGDS group (p = 0.011). Postoperative complications showed no significant difference between the two groups regarding mortality rate, pleural effusion, pancreatic injury, pulmonary infection, liver dysfunction, or postoperative abdominal bleeding. Postoperative platelet counts increased significantly more in the LEGDS group than in the LSEGDS group (p = 0.004). There were no significant differences in the long-term follow-up data, such as incidence of rebleeding, portal vein thrombosis, hepatic encephalopathy and survival (p > 0.05).
Conclusions: The LSEGDS is a safe and effective procedure for management of cirrhotic portal hypertension, especially in patients with visible paraesophageal veins.
Keywords: laparoscopic treatment; liver cirrhosis; portal hypertension; selective periesophagogastric devascularization; splenectomy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Laparoscopic versus open splenectomy and esophagogastric devascularization for bleeding varices or severe hypersplenism: a comparative study.J Gastrointest Surg. 2013 Apr;17(4):654-9. doi: 10.1007/s11605-013-2150-4. Epub 2013 Jan 29. J Gastrointest Surg. 2013. PMID: 23358846
-
Laparoscopic splenectomy and periesophagogastric devascularization with endoligature for portal hypertension in children.J Laparoendosc Adv Surg Tech A. 2009 Aug;19(4):545-50. doi: 10.1089/lap.2009.0087. J Laparoendosc Adv Surg Tech A. 2009. PMID: 19670979
-
Laparoscopic splenectomy via the spleen bed in combination with selective esophagogastric devascularization for patients with cirrhotic portal hypertension: a single-institution experience.Wideochir Inne Tech Maloinwazyjne. 2020 Sep;15(3):462-468. doi: 10.5114/wiitm.2019.89655. Epub 2019 Nov 11. Wideochir Inne Tech Maloinwazyjne. 2020. PMID: 32904588 Free PMC article.
-
Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience.Medicine (Baltimore). 2018 Dec;97(50):e13703. doi: 10.1097/MD.0000000000013703. Medicine (Baltimore). 2018. PMID: 30558084 Free PMC article.
-
Combined Laparoscopic Splenectomy and Esophagogastric Devascularization versus Open Splenectomy and Esophagogastric Devascularization for Portal Hypertension due to Liver Cirrhosis.Curr Med Sci. 2020 Feb;40(1):117-122. doi: 10.1007/s11596-020-2154-8. Epub 2020 Mar 13. Curr Med Sci. 2020. PMID: 32166673
Cited by
-
Management of Refractory Esophageal Variceal Bleeding when TIPSS Is Not Possible: Review of a Challenging Case.Case Rep Gastroenterol. 2025 Feb 13;19(1):67-71. doi: 10.1159/000543537. eCollection 2025 Jan-Dec. Case Rep Gastroenterol. 2025. PMID: 39949594 Free PMC article.
-
Application of the pancreatic body suspension technique in laparoscopic splenectomy combined with selective pericardial varicosity dissection: An observational study.Medicine (Baltimore). 2024 Sep 6;103(36):e39618. doi: 10.1097/MD.0000000000039618. Medicine (Baltimore). 2024. PMID: 39252307 Free PMC article.
-
Transjugular intrahepatic portosystemic shunt: a meta-analysis of 8 mm versus 10 mm stents.Wideochir Inne Tech Maloinwazyjne. 2021 Dec;16(4):623-632. doi: 10.5114/wiitm.2021.104198. Epub 2021 Mar 8. Wideochir Inne Tech Maloinwazyjne. 2021. PMID: 34950255 Free PMC article.
-
Robotic-assisted versus laparoscopic approach of Bai-Jiang-style vagus nerve-preserving splenectomy and azygoportal disconnection.Updates Surg. 2022 Oct;74(5):1773-1780. doi: 10.1007/s13304-022-01236-2. Epub 2022 Jan 7. Updates Surg. 2022. PMID: 34994944
-
Clinical efficacy of total laparoscopic splenectomy for portal hypertension and its influence on hepatic hemodynamics and liver function.World J Gastrointest Surg. 2023 Aug 27;15(8):1684-1692. doi: 10.4240/wjgs.v15.i8.1684. World J Gastrointest Surg. 2023. PMID: 37701706 Free PMC article.
References
-
- Chen XD, He FQ, Yang L, Yu YY, Zhou ZG. Laparoscopic splenectomy with or without devascularization of the stomach for liver cirrhosis and portal hypertension: a systematic review. ANZ J Surg. 2013;83:122–8. - PubMed
-
- Wang C, Xiao L, Han J, Jin CE, Peng Y, Yang Z. A prospective randomized trial of selective versus nonselective esophagogastric devascularization for portal hypertension. J Huazhong Univ Sci Technolog Med Sci. 2014;34:563–8. - PubMed
-
- Hashizume M, Tanoue K, Morita M, Ohta M, Tomikawa M, Sugimachi K. Laparoscopic gastric devascularization and splenectomy for sclerotherapy-resistant esophagogastric varices with hypersplenism. J Am Coll Surg. 1998;187:263–70. - PubMed
LinkOut - more resources
Full Text Sources